
SHARONAI HOLDINGS INC
SHAZNASDAQTrading Snapshot
- Day Range
- $56.03 β $57.24
- 52-Week Range
- $0.99 β $97.48
- Volume
- $2.71B
- Avg Volume
- $2.81B
- Shares Outstanding
- 35.4M
- Next Earnings
- Oct 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $267M
- Last Q Revenue
- $69M
- P/E Ratio
- β
- P/S Ratio
- β
- EPS (TTM)
- $-6.63
- Dividend Yield
- β
Why Investors Own SHAZ
- βHigh-growth profile β revenue up -3.1% YoY with expanding US Equity exposure.
- βHealthy economics β 66% gross margin and 7% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About SHARONAI HOLDINGS INC
A company profile for SHARONAI HOLDINGS INC isnβt available yet β check back soon.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates

SharonAI Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-10. The following slide deck was published by SharonAI Holdings Inc.

SharonAI Holdings Inc. (SHAZ) Q2 2026 Earnings Call Transcript
SharonAI Holdings Inc. (SHAZ) Q2 2026 Earnings Call August 6, 2026 4:30 PM EDTCompany ParticipantsRoss Barrows - Head of Capital Strategy & Investor...

SharonAI Holdings Inc. 2026 Q1 - Results - Earnings Call Presentation
2026-08-10. The following slide deck was published by SharonAI Holdings Inc.

Consumer Tech (Aug 3-7): SpaceX Released Strong First Earnings, Meta Sued For Harming Children's Mental Health & More
Consumer Tech (Aug 3-7): SpaceXΒ Released Strong First Earnings, Meta Sued For Harming Children's Mental Health & More

SharonAI Stock Dips Friday: What's Driving the Post-Earnings Pullback?
SharonAI Holdings Inc. (NASDAQ: SHAZ) shares are trading lower on Friday as investors digest the company's second-quarter earnings update.
Cantor Fitzgerald Maintains Overweight on SharonAI Holdings, Lowers Price Target to $109
Cantor Fitzgerald analyst Brett Knoblauch maintains SharonAI Holdings (NASDAQ:SHAZ) with a Overweight and lowers the price target from $116 to $109.